AKT1 and urinary bladder carcinoma: Given that gypenosides are likely to affect the PI3K/AKT/mTOR pathway in bladder cancer cells, which is crucial for cell survival, we evaluated the potential cytotoxic effect of gypenosides in human bladder cancer cell lines.